IC-5
IC-5, licence 80048796: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Bio Trust Nutrition LLC.
- NPN or DIN-HM
- 80048796
- Status
- Active licence
- Licence date
- 28 February 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 1,2-dithiolane-3-pentanoïque, (R) | 32.5 mg | Not calculated |
| Cinnamomum aromaticum Source : Ecorce (tronc) Extraction ratio : 4.0:1.0 Dry plant equivalent : 500 mg | 125.0 mg | Not calculated |
| Pterocarpus marsupium Source : Écorce âgée Extraction ratio : 8.0:1.0 Dry plant equivalent : 600 mg Potency : 5.0 % Pterostilbene | 75.0 mg | Not calculated |
| Pterocarpus marsupium Source : Stem heartwood Extraction ratio : 8.0:1.0 Dry plant equivalent : 600 mg Potency : 5.0 % Pterostilbene | 75.0 mg | Not calculated |
| 5,6-Dihydro-9,10-diméthoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Berberis aristata - Plante entière | 125.0 mg | Not calculated |
| Trigonella foenum-graecum Source : Semence(s) Extraction ratio : 10.0:1.0 Dry plant equivalent : 500 mg Potency : 50.0 % 4-Hydroxyisoleucine | 50.0 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Berberine helps support healthy cholesterol levels (serum triglycerides, total, and LDL). R-alpha-lipoic acid is an antioxidant. Cinnamon helps to support/maintain healthy glucose levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80048796
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.